Keeping Current

Which patients with Alagille syndrome benefit from IBAT inhibitors, and what should you watch for during therapy? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures:  https://www.medscape.org/viewarticle/navigating-management-alagille-syndrome-using-ileal-bile-2026a1000g3c?ecd=bdc_podcast_libsyn_mscpedu

How does it feel to live with CIDP? Bridge the gap between metrics and patient reality. Align goals and improve outcomes via shared decision-making. Credit available for this activity expires: 6/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-inflammatory-demyelinating-polyradiculoneuropathy-2026a1000g2n?ecd=bdc_podcast_libsyn_mscpedu

Do you know how the different therapies act in hemophilia A? Credit available for this activity expires: 05/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/molecular-nuances-hemostasis-differentiating-fviii-and-non-2026a1000hk2?ecd=bdc_podcast_libsyn_mscpedu

Can you untangle the threads linking depression and neurological disease to effectively treat your patients? Credit available for this activity expires: 06/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/depression-and-neurological-diseases-whats-link-2026a1000dco?ecd=bdc_podcast_libsyn_mscpedu

What is lacking in the care of your patients with myasthenia gravis? Find out how novel pathology-targeting therapies can meet unmet needs. Credit available for this activity expires: 5/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/what-lies-beneath-generalized-myasthenia-gravis-exploring-2026a1000fuh?ecd=bdc_podcast_libsyn_mscpedu

What do the latest clinical trial data tell us and how do they impact practice? Credit available for this activity expires: 5/20/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-new-frontiers-advanced-breast-cancer-milestones-2026a1000fu7?ecd=bdc_podcast_libsyn_mscpedu

Discover how dual sodium-glucose cotransporter 1/2 (SGLT1/2) inhibition can improve outcomes for your patients across the heart failure (HF) spectrum. Credit available for this activity expires: 05/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-sglt2-emerging-role-dual-sglt1-2-inhibition-heart-2026a1000es7?ecd=bdc_podcast_libsyn_mscpedu

Keep up with the move toward targeted disease modifying therapies in Sj ö gren's disease. Credit available for this activity expires: 05/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/addressing-unmet-needs-management-sj%C3%B6grens-disease-2026a1000dvs?ecd=bdc_podcast_libsyn_mscpedu

Recognize biliary atresia (BA) signs early to stop pediatric liver transplant. Gain expert insights on screening, diagnosis, and urgent referral pathways. Credit available for this activity expires: 05/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenges-and-opportunities-diagnostic-pathway-biliary-2026a1000bpb?ecd=bdc_podcast_libsyn_mscpedu

Improve real-world DME outcomes by mastering the interpretation of evolving biomarkers and the latest evidence on long-acting anti-VEGF therapies. Credit available for this activity expires: [04/28/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/diabetic-macular-edema-express-q-whats-new-2026a1000czk?ecd=bdc_podcast_libsyn_mscpedu

Sodium-glucose cotransporter 2 (SGLT2) inhibitors transformed HF care. Meet SGLT1, a transporter that may unlock even greater CV protection. Credit available for this activity expires: 4/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/science-sglt1-and-sglt2-unpacking-dual-inhibition-heart-2026a1000axj?ecd=bdc_podcast_libsyn_mscpedu

Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available? Credit available for this activity expires: 3/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/liver-fibrosis-type-2-diabetes-and-obesity-...

Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer? Credit available for this activity expires: 3/19/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu

Do you know when to suspect edema in uveitis and how to manage it? Credit available for this activity expires: 3/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-horizons-uveitic-macular-edema-2026a10007ij?ecd=bdc_podcast_libsyn_mscpedu

Do you know how to optimally identify, risk stratify, and treat your patients with obesity and MASLD or MASH? Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/metabolic-crossroads-navigating-obesity-liver-disease-axis-2026a10007kf?ecd=bdc_podcast_libsyn_mscpedu

What clinical trials led to updates in the treatment strategies for advanced/recurrent endometrial cancer? Credit available for this activity expires: 3/9/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?ecd=bdc_podcast_libsyn_mscpedu

Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices Credit available for this activity expires: 3/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-psma-preparing-your-practice-next-wave-prostate-2026a10006ql?ecd=bdc_podcast_libsyn_mscpedu

Do you know how many seizures is too many? Or what drugs to avoid in older epilepsy patients? Credit available for this activity expires: 3/3/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/avoiding-common-mistakes-managing-focal-epilepsy-2026a10004kv?ecd=bdc_podcast_libsyn_mscpedu

Are you optimizing inhaler choice and technique to achieve better outcomes? Credit available for this activity expires: 2/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/prescription-practice-respiratory-diseases-overcoming-2026a100058h?ecd=bdc_podcast_libsyn_mscpedu

Do you know how person-centred care can help address the challenges faced by chronic lymphocytic leukaemia (CLL) patients?   Credit available for this activity expires: 02/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cll-consultation-partnering-patients-person-centred-care-2026a10005ap?ecd=bdc_podcast_libsyn_mscpedu

Did you know that combining Bacillus Calmette-Guérin (BCG) with immunotherapy significantly improves outcomes in high-risk bladder cancer? Credit available for this activity expires: 2/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on HER2 testing best practices? Join our expert panel and discover the critical updates that guide treatment selection. Credit available for this activity expires: 2/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-her2-spectrum-breast-cancer-evolving-diagnostic-2026a10004ea?ecd=bdc_podcast_libsyn_mscpedu

What do the latest data from the 2025 breast cancer Winter Conference tell us? Credit available for this activity expires: 02/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/winter-conference-update-novel-and-emerging-treatment-2026a100030r?ecd=bdc_podcast_libsyn_mscpedu

Known as a "silent" disease because it has few or no symptoms, MASH increases cirrhosis, cancer, and death rates despite being both detectable and treatable. Credit available for this activity expires: 01/30/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-based-journey-risk-results-2026a10002fy?ecd=bdc_podcast_libsyn_mscpedu

Are you up-to-date on the latest data in HER2-positive early breast cancer? Join our experts as they discuss the data and the clinical implications! Credit available for this activity expires: 01/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-early-breast-cancer-what-latest-data-mean-your-2026a10002fg?ecd=bdc_podcast_libsyn_mscpedu